Transcriptome analysis in LRRK2 and idiopathic Parkinson's disease at different glucose levels
© 2021. The Author(s)..
Type-2 diabetes (T2D) and glucose metabolic imbalances have been linked to neurodegenerative diseases, including Parkinson's disease (PD). To detect potential effects of different glucose levels on gene expression, by RNA-seq we analyzed the transcriptome of dermal fibroblasts from idiopathic PD (iPD) patients, LRRK2-associated PD (L2PD) patients, and healthy controls (total n = 21 cell lines), which were cultured at two different glucose concentrations (25 and 5 mM glucose). In PD patients we identified differentially expressed genes (DEGs) that were related to biological processes mainly involving the plasmatic cell membrane, the extracellular matrix, and also neuronal functions. Such pathway deregulation was largely similar in iPD or L2PD fibroblasts. Overall, the gene expression changes detected in this study were associated with PD independently of glucose concentration.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
NPJ Parkinson's disease - 7(2021), 1 vom: 01. Dez., Seite 109 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fernández-Santiago, Rubén [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 04.04.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1038/s41531-021-00255-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333901967 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333901967 | ||
| 003 | DE-627 | ||
| 005 | 20240404233329.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41531-021-00255-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM333901967 | ||
| 035 | |a (NLM)34853332 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fernández-Santiago, Rubén |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Transcriptome analysis in LRRK2 and idiopathic Parkinson's disease at different glucose levels |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2021. The Author(s). | ||
| 520 | |a Type-2 diabetes (T2D) and glucose metabolic imbalances have been linked to neurodegenerative diseases, including Parkinson's disease (PD). To detect potential effects of different glucose levels on gene expression, by RNA-seq we analyzed the transcriptome of dermal fibroblasts from idiopathic PD (iPD) patients, LRRK2-associated PD (L2PD) patients, and healthy controls (total n = 21 cell lines), which were cultured at two different glucose concentrations (25 and 5 mM glucose). In PD patients we identified differentially expressed genes (DEGs) that were related to biological processes mainly involving the plasmatic cell membrane, the extracellular matrix, and also neuronal functions. Such pathway deregulation was largely similar in iPD or L2PD fibroblasts. Overall, the gene expression changes detected in this study were associated with PD independently of glucose concentration | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Esteve-Codina, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández, Manel |e verfasserin |4 aut | |
| 700 | 1 | |a Valldeoriola, Francesc |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez-Gómez, Almudena |e verfasserin |4 aut | |
| 700 | 1 | |a Muñoz, Esteban |e verfasserin |4 aut | |
| 700 | 1 | |a Compta, Yaroslau |e verfasserin |4 aut | |
| 700 | 1 | |a Tolosa, Eduardo |e verfasserin |4 aut | |
| 700 | 1 | |a Ezquerra, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Martí, María J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t NPJ Parkinson's disease |d 2015 |g 7(2021), 1 vom: 01. Dez., Seite 109 |w (DE-627)NLM259702250 |x 2373-8057 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2021 |g number:1 |g day:01 |g month:12 |g pages:109 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41531-021-00255-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2021 |e 1 |b 01 |c 12 |h 109 | ||